F. A. Pereira, T. Fallows, M. Frank, A. Chen, G. H. Clever
ARTICLE
OЈKeeffe, O. Yaghi, Angew. Chem. Int. Ed. 2008, 47, 5136; d) R.
Chakrabarty, P. S. Mukherjee, P. J. Stang, Chem. Rev. 2011, 111,
6810; e) T. K. Ronson, S. Zarra, S. P. Black, J. R. Nitschke, Chem.
Commun. 2013, 2476.
2.8 mM solution of [PdCl2(2a,b)] in CD3CN (6.3 μmol in 2.25 mL)
was prepared and added to a 11.24 mM solution of AgBF4 in CD3CN
(23.6 μmol in 2.10 mL) in 1:2 equivalence. The mixture was shaken
well and kept in a dark place for 1 h at room temperature. AgCl pre-
cipitatet as a grey solid. 1H NMR [Pd(2a)(CD3CN)2](BF4)2 (CD3CN):
δ = 7.64 (ddd, 7.5, 5.8 1.6 Hz, 2 H, H5), 7.71 (dd, 5.8, 3.3 Hz, 2 H,
H2), 7.96–7.88 (m, 4 H, H3, H1), 8.09 (td, 7.8, 1.5 Hz, 2 H, H4), 8.90
(ddd, 5.8, 1.5, 0.7 Hz, 2 H, H6). 1H NMR [Pd(2b)(CD3CN)2](BF4)2
(CD3CN): δ = 0.35 (s, 12 H, Si-CH3), 1.06 (s, 18 H, tBu), 7.45 (s, 2
H, H2), 7.62 (ddd, 2 H, 5 H), 7.89 (d, 2 H, H3), 8.07 (td, 2 H, H4),
8.89 (m, 2 H, H6).
[2] M. Fujita, J. Yazaki, K. Ogura, J. Am. Chem. Soc. 1990, 112,
5645–5647.
[3] P. Stang, D. Cao, J. Am. Chem. Soc. 1994, 116, 4981–4982.
[4] M. Fujita, K. Umemoto, M. Yoshizawa, N. Fujita, T. Kusukawa,
K. Biradha, Chem. Commun. 2001, 509–518.
[5] C. H. Amijs, G. P. van Klink, G. van Koten, Dalton Trans. 2006,
308–327.
[6] J. Navarro, M. Janik, E. Freisinger, B. Lippert, Inorg. Chem.
1999, 38, 426–432.
[7] R. Schnebeck, E. Freisinger, B. Lippert, Angew. Chem. Int. Ed.
1999, 38, 168–171.
[8] M. Schmidtendorf, T. Pape, F. E. Hahn, Angew. Chem. Int. Ed.
2012, 51, 2195–2198.
[9] R. V. Slone, J. T. Hupp, C. L. Stern, T. E. Albrecht-Schmitt, Inorg.
Chem. 1996, 35, 4096–4097.
[10] V. C. Lau, L. A. Berben, J. R. Long, J. Am. Chem. Soc. 2002,
124, 9042–9043.
Synthesis of [Pd(2c)(CD3CN)2](BF4)2: [Pd(CH3CN)4](BF4)2 (12
μmol, 1.2 equiv.) and 2c (10 μmol, 1 equiv.) were combined in 1 mL
of CD3CN to form a 1 mM solution of [Pd(2c)(CD3CN)2](BF4)2 1H
NMR (CD3CN): δ = 7.44–7.39 (m, 2 H, H7), 7.76–7.70 (m, 2 H, H8),
7.82 (ddd, 7.6 5.9, 1.6 Hz, 2 H, H5), 8.07 (ddd, 7.9, 1.6, 0.7 Hz, 2 H,
H3), 8.24 (ts, 7.8, 1.5 Hz, 2 H, H4), 8.46 (s, 2 H, H2), 9.04 (ddd, 5.9,
1.5, 0.7 Hz, 2 H, H6).
[11] F. Würthner, C.-C. You, C. R. Saha-Möller, Chem. Soc. Rev. 2004,
Synthesis of three-membered Ring (4a): A solution of 3 (50 μL, 7 m)
in CD3CN and a solution of [Pd(2a)(CD3CN)2]2+ (500 μL, 0.7 m) in
CD3CN were combined in a 1:1 ratio. The mixture was shaken well
and left at room temperature for 10 min. to form 4a. 1H NMR
(CD3CN): δ = 3.22 (s, 18 H, Hg), 3.48–3.54 (m, 12 H, Hf), 4.09–4.15
(m, 12 H, He), 7.83–7.77 (m, 12 H, H5, Hb), 7.91–7.96 (m, 6 H, H2),
7.96–7.91 (m, 6 H, H2), 8.02–7.98 (m, 18 H, H3, Ha), 8.07 (td, 7.8,
1.5 Hz, 6 H, H4), 8.22–8.17 (m, 6 H, H1), 8.93 (d, 4.2 Hz, 6 H, Hc),
9.29 (d, 3 Hz, 6 H, Hd), 9.57 (d, 6.3 Hz, 6 H, H6). ESI HRMS: m/z
([C126H108N12O12Pd3B2F8]4+) found: 618.6391 calcd.: 618.6356.
33, 133–146.
[12] R. Schnebeck, E. Freisinger, B. Lippert, Chem. Commun. 1999,
675–676.
[13] S. Shanmugaraju, A. K. Bar, K.-W. Chi, P. S. Mukherjee, Organo-
metallics 2010, 29, 2971–2980.
[14] E. Bosch, C. L. Barnes, Inorg. Chem. 2001, 40, 3097–3100.
[15] Y.-Z. Hu, C. Chamchoumis, J. S. Grebowicz, R. P. Thummel, In-
org. Chem. 2002, 41, 2296–2300.
[16] S. Shotwell, H. Ricks, J. Morton, M. Laskoski, J. Fiscus, M.
Smith, K. Shimizu, H.-C. zur Loye, U. H. F. Bunz, J. Organomet.
Chem. 2003, 671, 43–51.
[17] E. Bosch, N. Schultheiss, N. Rath, M. Bond, Cryst. Growth Des.
2003, 3, 263–266.
[18] J. E. Fiscus, S. Shotwell, R. C. Layland, R. E. Hipp, A. M. Go-
forth, C. T. Chapman, M. D. Smith, U. H. F. Bunz, H.-C.
zur Loye, J. Chem. Crystallogr. 2005, 35, 903–912.
[19] E. Isomura, K.-I. Tokuyama, T. Nishinaga, M. Iyoda, Tetrahedron
Lett. 2007, 48, 5895–5898.
[20] E. Bosch, C. L. Barnes, N. L. Brennan, G. L. Eakins, B. E. Brey-
fogle, J. Org. Chem. 2008, 73, 3931–3934.
[21] N. L. Brennan, C. L. Barnes, E. Bosch, Inorg. Chim. Acta 2010,
363, 3987–3992.
Synthesis of three-membered Ring (4c): A solution of 3 (1.03 mL,
3 mM) in CD3CN and a solution of [Pd(2c)(CD3CN)2]2+ (300 μL,
10.3 mM) were combined in CD3CN. The mixture was shaken well
and left at room temperature for 10 min. to form 4c. 1H NMR
(CD3CN): δ = 3.21 (s, 18 H, Hg), 3.54–3.51 (m, 12 H, Hf), 4.13–4.10
(m, 12 H, He), 7.44 (d, 8.7 Hz, 6 H, H7), 7.61 (d, 8.4 Hz, 6 H, H8),
7.78–7.73 (m, 12 H, H5, Hb), 7.88 (s, 12 H, Ha), 8.11–7.99 (m, 12 H,
H4, H3), 8.68 (s, 6 H, H2), 8.81 (d, 2.5 Hz, 6 H, Hc), 9.24–9.21 (m, 6
H, Hd), 9, 49 (d, 5.9 Hz, 6 H, H6).
[22] M. Jung, Y. Suzaki, T. Saito, K. Shimada, K. Osakada, Polyhe-
dron 2012, 40, 168–174.
Synthesis of two-membered Ring (6a): A solution of 5[25] (250 μL,
2.8 m) in CD3CN and a solution of [Pd(2a)(CD3CN)2]2+ were com-
bined in CD3CN (1 mL, 0.7 m). The mixture was shaken well and left
for 5 min at room temperature to form 6a. 1H NMR (CD3CN): δ =
3.28 (s, 4 H, Hh), 7.41 (d, 4 H, Hb), 7.53 (ddd, 8.1, 5.8, 0.7 Hz, 4 H,
H5), 7.76–7.67 (m, 8 H, Hd, Hc), 7.95–7.86 (m, 8 H, H3, H2), 8.08–
7.99 (m, 8 H, H4, He), 8.18–8.10 (m, 4 H, H1, Ha), 9.16–9.12 (m, 4
H, Hf), 9.26 (dd, 1.6, 0.9 Hz, 4 H, Hg), 9.42 (m, 4 H, H6). ESI MS:
m/z ([C98H60N8O2Pd2BF4)]3+) found: 560.4133 calcd.: 560.4324.
[23] A similar ligand was used to form self-assembled dinuclear rec-
tangular boxes, however, showing a different, non-chelating bind-
ing mode: T. Kawano, J. Kuwana, C.-X. Du, I. Ueda, Inorg.
Chem. 2002, 41, 4078–4080.
[24] Batch by batch, the 1H NMR spectrum of the in situ prepared
[Pd(2a)(CD3CN)2](BF4)2 may contain a second set of signals of
varying intensity which might be assigned to chloride containing
species being in equilibrium with the target compound. Neverthe-
less, these solutions could also be used for the subsequent ring
formation.
[25] S. Freye, J. Hey, A. Torras-Galán, D. Stalke, R. Herbst-Irmer, M.
John, G. H. Clever, Angew. Chem. Int. Ed. 2012, 51, 2191–2194.
[26] S. Freye, D. M. Engelhard, M. John, G. H. Clever, Chem. Eur. J.
2013, 19, 2114–2121.
[27] J. M. Dieterich, G. H. Clever, R. A. Mata, Phys. Chem. Chem.
Phys. 2012, 14, 12746–12749.
Acknowledgments
This work was supported by the Deutsche Forschungsgemeinschaft
(DFG) IRTG 1422 (Metal Sites in Biomolecules). FAP thanks the DFG
and MF the Evonik Foundation for PhD fellowships. TF thanks the
Erasmus Program for financial support.
[28] S. De, K. Mahata, M. Schmittel, Chem. Soc. Rev. 2010, 39, 1555–
1575.
[29] M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A.
Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci,
G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian,
A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada,
M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T.
Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Mont-
References
[1] a) J. W. Steed, J. L. Atwood, Supramolecular Chemistry, Wiley-
VCH, 2009; b) G. H. Clever, in: Molecules at Work (Ed.: B. Pig-
nataro), Wiley-VCH, 2012; c) D. Tranchemontagne, Z. Ni, M.
1604
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Z. Anorg. Allg. Chem. 2013, 1598–1605